Study of the Effects and Mechanisms of Ginsenoside Compound K on

2 days ago - Jiahong Han , Yu Wang , Enbo Cai , Lianxue Zhang , Yan Zhao , Nian Sun , Xiaoman Zheng , and Siqi Wang. J. Agric. Food Chem. , Just ...
0 downloads 0 Views 665KB Size
Subscriber access provided by Service des bibliothèques | Université de Sherbrooke

Bioactive Constituents, Metabolites, and Functions

Study of the Effects and Mechanisms of Ginsenoside Compound K on Myelosuppression Jiahong Han, Yu Wang, Enbo Cai, Lianxue Zhang, Yan Zhao, Nian Sun, Xiaoman Zheng, and Siqi Wang J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b06073 • Publication Date (Web): 10 Jan 2019 Downloaded from http://pubs.acs.org on January 11, 2019

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 29

Journal of Agricultural and Food Chemistry

1

Study of the Effects and Mechanisms of Ginsenoside Compound K on

2

Myelosuppression

3

Jiahong Han, Yu Wang, Enbo Cai*, Lianxue Zhang, Yan Zhao, Nian Sun,

4

Xiaoman Zheng, Siqi Wang

5

College of Chinese Medicinal Material, Jilin Agricultural University

6

*Dr.

Enbo Cai, College of Chinese Medicinal Material, Jilin Agricultural University, Xincheng Street No. 2888, Changchun Jilin province, 130118, China *Corresponding

author: Enbo Cai, College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun Jilin province, 130118, China. E-mail:[email protected],tel.:13944816620. 1

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

7

Study of the Effects and Mechanisms of Ginsenoside Compound K on

8

Myelosuppression

9

10

Abstract: Ginsenoside compound K (CK) is not a ginsenoside naturally exist in

11

Panax ginseng Meyer. However, CK is a major metabolite of ginsenoside Rb1.,Rb2 or

12

Rc in the intestine under the effects of bacteria. In this study, we first investigated the

13

effects of CK on myelosuppression in mice induced by cyclophosphamide (CTX).

14

The respective quantities of white blood cell (WBC), blood platelet (PLT) and bone

15

marrow nucleated cells (BMNC) were determined to be 8.54±0.91 (109/L),

16

850.90±44.11 (109/L) and 1.45±0.22 (109/L) in the CK-H group by detecting

17

peripheral blood cells and BMNC. CK-H and CK-L both increased the thymus index

18

by up to 0.62±0.06 (mg/g) and 0.52±0.09 (mg/g), respectively, and significantly

19

increased the yields of CFU-GM and CFU-Meg. According to our study, CK could

20

control apoptosis and promote cells enter the normal cell cycle by bcl-2/bax signaling

21

pathway and MEK/ERK signaling pathway. Therefore, the BMNC could proliferate

22

and differentiate normally after enter the normal cell cycle. So the peripheral blood

23

cells could show a trend of returning to normal. The recovery of peripheral blood cells

24

resulting in the level of cytokines tend to normal. This process may be the

25

mechanisms of CK on myelosuppression. This study provides a reference for ginseng

26

in the treatment of myelosuppression.

27

28

Keywords: ginsenoside compound K (CK) , myelosuppression , chemotherapy, 2

ACS Paragon Plus Environment

Page 2 of 29

Page 3 of 29

Journal of Agricultural and Food Chemistry

29

cytoxan(CTX), hematopoietic function

30

3

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

31

Page 4 of 29

INTRODUCTION

32

Chemotherapy is the most widely used treatment for cancer since

33

chemotherapeutic agents can act on the abnormally active cancer cells throughout the

34

whole body 1. However, these agents also have destructive effects on normal rapidly

35

proliferating cells such as blood cells, stomach cells, and especially hematopoietic

36

stem cells (HSCs) while destroying cancer cells 2. CTX is the most widely used

37

medicine with a high therapeutic index in chemotherapy. CTX can against a variety of

38

cancers by damaging intracellular DNA molecules directly 3, affecting cell division

39

and inducing apoptosis of HSC 4-5.

40

Myelosuppression is a common toxic reaction of most chemotherapeutic agents.

41

The clinical manifestation of myelosuppression is the decrease of blood cells in

42

peripheral

43

thrombocytopenia 7. The infection caused by leukopenia and the bleeding caused by

44

thrombocytopenia both

45

Therefore, determining how to effectively alleviate myelosuppression during

46

chemotherapy is a problem that must be addressed.

blood

6.

Then

triggered

leukopenia,

neutropenia,

anemia

and

seriously affect the patient's treatment and prognosis 8.

47

Ginseng is the root of Panax ginseng C. A. Mey. It is a traditional Chinese

48

medicine and has been widely used all over the world nowadays. Ginsenosides are

49

considered to be the main active compounds 9. Ginsenoside compound K (CK) does

50

not exist in ginseng

51

Rb1.,Rb2 or Rc in the intestine under the effects of bacteria 12. CK is considered a rare

52

ginsenoside and has received much attention because of its bioactivities

53

However, there have been no studies on the effects of CK on myelosuppression.

10-11.

Nonetheless, CK is a major metabolite of ginsenoside

4

ACS Paragon Plus Environment

13-14.

Page 5 of 29

Journal of Agricultural and Food Chemistry

54

We speculate that CK has effect on myelosuppression mice. So in this study, we

55

compared the count of blood cells, bone marrow nucleated cells (BMNC), and thymus

56

and spleen index before and after treatment with CK.. We explored the mechanism of

57

action by investigating the effects of CK on the proliferation and differentiation of

58

hematopoietic progenitor cells, the influence on the bone marrow cell cycle and the

59

level of hematopoiesis-related cytokines and the expression of proteins.

60

MATERIALS AND METHODS

61

Chemicals. CK was obtained from the Jilin University (Changchun, China). It

62

was 99.5% pure, as confirmed by HPLC. CTX was purchased from Jiangsu Shengdi

63

Pharmaceutical Co., Ltd (Jiangsu, China). Mouse cytokines were obtained from

64

novoprotein Scientific Inc. (Shanghai, China). ELISA kits was supplied by R&D

65

systems (Minneapolis, MN, USA). Antibodies were obtained from Cell Signaling

66

Technology (Danvers, MA, USA). The propidium iodide was supplied by Tianjin

67

Sungene Biotech Co., Ltd (Tianjin, China). PVDF membrane (Millipore , USA),

68

Medical X-ray film (Eastman Kodak Company ,

69

(AB85157, Abcam, UK), anti-Bcl-2 antibody (AB59348, Abcam, UK), anti-caspase-3

70

antibody (AB13847, Abcam, UK), anti-MEK antibody (AB33918, Abcam, UK),

71

anti-p-ERK antibody (AB194770, Abcam, UK).

USA), anti-Bax antibody

72

Experimental Animals. BALB/c mice, male, 18 g ~ 22 g. Provided by the

73

Laboratory Animal Quality Testing Center of Jilin Province (No: SCXK-2016-0003).

74

After 7 days adaptation prior to the experiment. The temperature was controlled at

75

22±2°C and humidity was at 50%±10%. Adjusted to 12 h light and 12 h dark. All

76

efforts were to reduce the pain of the mice. Whole process obeid the rules of National 5

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

77

Institute of Health Guide for the Care and Use of Laboratory Animals. The study was

78

approved by the Animal Ethics Committee of the China Academy.

79

The mice were divided into five groups: Normal, Model, Positive, CK-L and

80

CK-H. Intraperitoneally (i.p.) injected the mice in 2-5 groups with CTX (100 mg·kg–1,

81

0.1 mL·10 g–1) and in group 1 with equal volume of saline (0.9% NaCl aq) for 3 days.

82

After CTX treatment for 24 hours, i.p. injected the Positive group with rhG-CSF

83

(11.25 μg·kg–1), the CK-L group with CK (5 mg·kg–1), the CK-H group with CK (10

84

mg·kg–1) and the Normal and the Model groups with equivalent volume of saline

85

(0.9% NaCl aq) for 7 days.

86

Determination of Peripheral Blood Cells. On Day 11, collected blood samples

87

from the eye socket vein. after the eyeballs were removed, and the samples were

88

placed into test tubes with ethylenediaminetetraacetic acid (EDTA). Counted white

89

blood cells (WBC), red blood cells (RBC), hemoglobin (HGB) and platelets (PLT) by

90

automated hematology analyzer (Sysmex KX-21N, Japan).

91

Determination of Thymus and Spleen Index. Measured the weights of the

92

mice after the last .i.p. injection. Sacrificed the mice and remove the thymus and

93

spleen. Weighed and calculated the thymus and spleen index.

94

The Preparation of Bone Marrow Nucleated Cell Suspension. Removed the

95

femurs under aseptic conditions then used sterile phosphate-buffered saline (PBS)

96

flushing bone marrow cells to form a single cell suspension. The bone marrow

97

nucleated cell suspension from 10 mice was randomly divided into two parts; one was

98

used for the count of BMNCs, hematopoietic progenitor cell culture and cell cycle,

99

while the other was used for western blotting. 6

ACS Paragon Plus Environment

Page 6 of 29

Page 7 of 29

Journal of Agricultural and Food Chemistry

100

Bone Marrow Nucleated Cells. Centrifuged the suspension for 10 min at 1200

101

r/min then added RBC lysis buffer 2 ml. After standed for 3 min, centrifuged the

102

mixture at 1200 r/min for 10 min. Rinsed the bone marrow karyocytes twice with

103

sterile PBS 1 mL at 1200 r/min for 10 min. Counted by inverted microscope.

104

HPCs Culture. Adjusted BMNC to a concentration of 105/mL. Inoculated bone

105

marrow cells into the IMDM medium for colony formation units-granulocyte

106

monocyte (CFU-GM), colony formation units-megakaryocytic(CFU-Meg), colony

107

formation units-erythroid(CFU-E) and burst-forming unit-erythroid(BFU-E). Cultured

108

BMNC at 37°C under 5% CO2 atmosphere. CFU-E were counted under inverted

109

phase contrast microscope after 3 days of culture. BFU-E, CFU-GM and CFU-Meg

110

were counted after 7 days of culture.

111 112

The Levels of Hematopoiesis-related Cytokines in Plasma. Prepared plasma samples and measured the levels of EPO, TPO and GM-CSF by ELISA.

113

Cell Cycle. Centrifuged single cell suspension after rinsed it twice with cold

114

PBS. Added to 70% cold ethanol 2 mL and fix the cells at 4°C overnight. Then

115

incubated cells with propidium iodide in the dark for 30 min. Measured cells by flow

116

cytometry and calculated proliferation index (PI) by the following formula.

S  G2 / M  100% G 0 / G1  S  G 2 / M

117

PI 

118

Expression of Related Protein. Determined the ation of protein content by

119

western blotting. Extracted the protein in BMNC and determined the protein

120

concentration by the Bradford method. Separated protein samples by SDS-PAGE

121

electrophoresis and transferred to PVDF membrane. Blocked in 5% skim milk 7

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

122

solution for 1 hand added primary antibody. Incubated the samples at 4°C overnight.

123

Incubated the samples for 1 h after added a secondary antibody. Chemiluminescence

124

was used to develop the color. Analyzed the protein bands quantitatively after scanned

125

the film. Obtained the expression level of protein.

126

Statistical Analysis. Expressed data as the mean ± SD. The data were

127

statistically analyzed by one way ANOVA, post-hoc Student-Newman-Keuls test.

128

Considered a value of P